BACKGROUND: Despite advances in the field of lung transplantation, the median survival after lung transplant remains below 5 years. Early rejection is a risk factor for the development of chronic rejection. In animal models of transplant tolerance, regulatory T cells (Tregs) can prevent the establishment of rejection. METHODS: This study was designed to explore the dynamics of Tregs focally and systemically in lung transplant recipients. Sequential surveillance bronchoscopy results were available in 51 patients with at least four sequential samples recovered from each patient at defined times posttransplant. In 36 individuals, a complete year of follow-up data for BAL was analyzed. In 33 of these individuals had a complete year of follow-up data for peripheral blood monocyte cell specimens were also analyzed. Lung lavage cells were recovered from each bronchoscopy and corresponding blood draw and subjected to polychromatic flow cytometry. The percentage of CD4 lymphocytes, which expressed the intracellular transcription factor FoxP3 was recorded at each point. At each time point, lung biopsy specimens were scored for rejection. RESULTS: Lung Treg frequency was significantly more variable than blood Treg frequency. Treg frequency in the lung was increased in the aftermath of acute rejection. In contrast, lung Treg frequency declined sequentially in patients demonstrating continued quiescence. Mean BAL Treg level integrated over the first transplant year correlated inversely with the degree of acute cellular rejection. In contrast, blood Treg levels demonstrated no correlation with lung pathology. CONCLUSIONS: Lung Tregs increase in the setting of acute cellular rejection, whereas declining levels of BAL Tregs correlates with immunologic quiescence.
BACKGROUND: Despite advances in the field of lung transplantation, the median survival after lung transplant remains below 5 years. Early rejection is a risk factor for the development of chronic rejection. In animal models of transplant tolerance, regulatory T cells (Tregs) can prevent the establishment of rejection. METHODS: This study was designed to explore the dynamics of Tregs focally and systemically in lung transplant recipients. Sequential surveillance bronchoscopy results were available in 51 patients with at least four sequential samples recovered from each patient at defined times posttransplant. In 36 individuals, a complete year of follow-up data for BAL was analyzed. In 33 of these individuals had a complete year of follow-up data for peripheral blood monocyte cell specimens were also analyzed. Lung lavage cells were recovered from each bronchoscopy and corresponding blood draw and subjected to polychromatic flow cytometry. The percentage of CD4 lymphocytes, which expressed the intracellular transcription factor FoxP3 was recorded at each point. At each time point, lung biopsy specimens were scored for rejection. RESULTS: Lung Treg frequency was significantly more variable than blood Treg frequency. Treg frequency in the lung was increased in the aftermath of acute rejection. In contrast, lung Treg frequency declined sequentially in patients demonstrating continued quiescence. Mean BAL Treg level integrated over the first transplant year correlated inversely with the degree of acute cellular rejection. In contrast, blood Treg levels demonstrated no correlation with lung pathology. CONCLUSIONS: Lung Tregs increase in the setting of acute cellular rejection, whereas declining levels of BAL Tregs correlates with immunologic quiescence.
Authors: C L Lau; S M Palmer; K E Posther; D N Howell; N L Reinsmoen; H T Massey; V F Tapson; J J Jaggers; T A D'Amico; R D Davis Journal: Ann Thorac Surg Date: 2000-05 Impact factor: 4.330
Authors: Xin Xiao Zheng; Alberto Sánchez-Fueyo; Masayuki Sho; Christoph Domenig; Mohamed H Sayegh; Terry B Strom Journal: Immunity Date: 2003-10 Impact factor: 31.745
Authors: James E Fildes; Nizar Yonan; Katie Tunstall; Antony H Walker; Lorraine Griffiths-Davies; Paul Bishop; Colm T Leonard Journal: J Heart Lung Transplant Date: 2008-02 Impact factor: 10.247
Authors: Anthony P Khalifah; Ramsey R Hachem; Murali M Chakinala; Kenneth B Schechtman; G Alexander Patterson; Daniel P Schuster; Thalachallour Mohanakumar; Elbert P Trulock; Michael J Walter Journal: Am J Respir Crit Care Med Date: 2004-05-06 Impact factor: 21.405
Authors: Shuang Fu; Nan Zhang; Adam C Yopp; Dongmei Chen; Minwei Mao; Dan Chen; Haojiang Zhang; Yaozhong Ding; Jonathan S Bromberg Journal: Am J Transplant Date: 2004-10 Impact factor: 8.086
Authors: Aric L Gregson; Aki Hoji; Patil Injean; Steven T Poynter; Claudia Briones; Vyacheslav Palchevskiy; S Sam Weigt; Michael Y Shino; Ariss Derhovanessian; David Sayah; Rajan Saggar; David Ross; Abbas Ardehali; Joseph P Lynch; John A Belperio Journal: Am J Respir Crit Care Med Date: 2015-12-15 Impact factor: 21.405
Authors: Andrew E Gelman; Andrew J Fisher; Howard J Huang; Maher A Baz; Ciara M Shaver; Thomas M Egan; Micheal S Mulligan Journal: J Heart Lung Transplant Date: 2017-07-24 Impact factor: 10.247
Authors: J R Greenland; N P Jewell; M Gottschall; N N Trivedi; J Kukreja; S R Hays; J P Singer; J A Golden; G H Caughey Journal: Am J Transplant Date: 2014-02-11 Impact factor: 8.086
Authors: D C Neujahr; K Uppal; S D Force; F Fernandez; C Lawrence; A Pickens; R Bag; C Lockard; A D Kirk; V Tran; K Lee; D P Jones; Y Park Journal: Am J Transplant Date: 2014-02-19 Impact factor: 8.086
Authors: David San Segundo; María Ángeles Ballesteros; Sara Naranjo; Felipe Zurbano; Eduardo Miñambres; Marcos López-Hoyos Journal: PLoS One Date: 2013-11-13 Impact factor: 3.240